Guideline for the prevention of oral and oropharyngeal mucositis in children receiving treatment for cancer or undergoing haematopoietic stem cell transplantation

BMJ Supportive and Palliative Care

Volumn 7, Issue 1, 2017, Pages 7-16

  Sung, Lillian ^a   Robinson, Paula ^b   Treister, Nathaniel ^c   Baggott, Tina ^d   Gibson, Paul ^e   Tissing, Wim ^f   Wiernikowski, John ^g   Brinklow, Jennifer ^h   Dupuis, L Lee ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b PEDIATRIC ONCOLOGY GROUP OF ONTARIO   (Canada)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d STANFORD UNIVERSITY   (United States)

^e UNIVERSITY OF WESTERN ONTARIO   (Canada)

^f UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^g MCMASTER CHILDREN S HOSPITAL   (Canada)

^h CHILDREN S HOSPITAL OF EASTERN ONTARIO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

KERATINOCYTE GROWTH FACTOR;

ADOLESCENT; CHILD; CRYOTHERAPY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; INFANT; MUCOSITIS; NEOPLASMS; PHARYNGEAL DISEASES; PHOTOTHERAPY; PRACTICE GUIDELINE; PRESCHOOL CHILD; PROCEDURES; STOMATITIS;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; CRYOTHERAPY; FIBROBLAST GROWTH FACTOR 7; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INFANT; MUCOSITIS; NEOPLASMS; PHARYNGEAL DISEASES; PHOTOTHERAPY; PRACTICE GUIDELINES AS TOPIC; STOMATITIS;

EID: 85014105353     PISSN: 2045435X     EISSN: 20454368     Source Type: Journal    
DOI: 10.1136/bmjspcare-2014-000804     Document Type: Review

References (50)

1. Ethier MC, Regier DA, Tomlinson D, et al. Perspectives toward oral mucositis prevention from parents and health care professionals in pediatric cancer. Support Care Cancer 2012;20:1771-7.
2. Al-Dasooqi N, Sonis ST, Bowen JM, et al. Emerging evidence on the pathobiology of mucositis. Support Care Cancer 2013;21:3233-41.
3. Tunkel AR, Sepkowitz KA. Infections caused by viridans streptococci in patients with neutropenia. Clin Infect Dis 2002;34:1524-9.
4. Sonis ST. Oral complications of cancer therapy. In: De Vita VT Jr, Hellman S, Rosenberg SA, eds. Principles and practices of oncology. Philadelphia: Lippincott-Raven, 1993:2385-94.
5. Carlotto A, Hogsett VL, Maiorini EM, et al. The economic burden of toxicities associated with cancer treatment: review of the literature and analysis of nausea and vomiting, diarrhoea, oral mucositis and fatigue. Pharmacoeconomics 2013;31: 753-66.
6. American Academy of Pediatric Dentistry. Policy on oral health care programs for infants, children, and adolescents. Oral Health Policies, 2011.
7. Worthington HV, Clarkson JE, Bryan G, et al. Interventions for preventing oral mucositis for patients with cancer receiving treatment. Cochrane Database Syst Rev 2011;(4):CD000978.
8. Peterson DE, Ohrn K, Bowen J, et al. Systematic review of oral cryotherapy for management of oral mucositis caused by cancer therapy. Support Care Cancer 2013;21:327-32.
9. Raber-Durlacher JE, von Bultzingslowen I, Logan RM, et al. Systematic review of cytokines and growth factors for the management of oral mucositis in cancer patients. Support Care Cancer 2013;21:343-55.
10. Gibson RJ, Keefe DMK, Lalla RV, et al. Systematic review of agents for the management of gastrointestinal mucositis in cancer patients. Support Care Cancer 2013;21:313-26.
11. Yarom N, Ariyawardana A, Hovan A, et al. Systematic review of natural agents for the management of oral mucositis in cancer patients. Support Care Cancer 2013;21:3209-21.
12. Lalla RV, Bowen J, Barasch A, et al. MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy. Cancer 2014;120:1453-61.
13. McGuire DB, Fulton JS, Park J, et al. Systematic review of basic oral care for the management of oral mucositis in cancer patients. Support Care Cancer 2013;21:3165-77.
14. Migliorati C, Hewson I, Lalla RV, et al. Systematic review of laser and other light therapy for the management of oral mucositis in cancer patients. Support Care Cancer 2013;21:333-41.
15. Nicolatou-Galitis O, Sarri T, Bowen J, et al. Systematic review of anti-inflammatory agents for the management of oral mucositis in cancer patients. Support Care Cancer 2013;21:3179-89.
16. Nicolatou-Galitis O, Sarri T, Bowen J, et al. Systematic review of amifostine for the management of oral mucositis in cancer patients. Support Care Cancer 2013;21:357-64.
17. Saunders DP, Epstein JB, Elad S, et al. Systematic review of antimicrobials, mucosal coating agents, anesthetics, and analgesics for the management of oral mucositis in cancer patients. Support Care Cancer 2013;21:3191-207.
18. Guyatt GH, Oxman AD, Vist GE, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ 2008;336:924-6.
19. Guyatt GH, Oxman AD, Kunz R, et al. GRADE: going from evidence to recommendations. BMJ 2008;336:1049-51.
20. Gori E, Arpinati M, Bonifazi F, et al. Cryotherapy in the prevention of oral mucositis in patients receiving low-dose methotrexate following myeloablative allogeneic stem cell transplantation: a prospective randomized study of the Gruppo Italiano Trapianto di Midollo Osseo nurses group. Bone Marrow Transplant 2007;39:347-52.
21. Schulz KF, Chalmers I, Hayes RJ, et al. Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA 1995;273:408-12.
22. Chung H, Dai T, Sharma S, et al. The nuts and bolts of lowlevel laser (light) therapy. Ann Biomed Eng 2012;40:516-33.
23. Oberoi S, Zamperlini-Netto G, Beyene J, et al. Effect of prophylactic low level laser therapy on oral mucositis: a systematic review and meta-analysis. PLoS ONE 2014;9:e107418.
24. Schubert MM, Eduardo FP, Guthrie KA, et al. A phase III randomized double-blind placebo-controlled clinical trial to determine the efficacy of low level laser therapy for the prevention of oral mucositis in patients undergoing hematopoietic cell transplantation. Support Care Cancer 2007;15:1145-54.
25. Cruz LB, Ribeiro AS, Rech A, et al. Influence of low-energy laser in the prevention of oral mucositis in children with cancer receiving chemotherapy. Pediatr Blood Cancer 2007;48:435-40.
26. Higgins JPT, Green S, eds. Cochrane handbook for systematic reviews of interventions, Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011.
27. Blazar BR, Weisdorf DJ, Defor T, et al. Phase 1/2 randomized, placebo-control trial of palifermin to prevent graft-versus-host disease (GVHD) after allogeneic hematopoietic stem cell transplantation (HSCT). Blood 2006;108:3216-22.
28. Levine JE, Blazar BR, Defor T, et al. Long-term follow-up of a phase I/II randomized, placebo-controlled trial of palifermin to prevent graft-versus-host disease (GVHD) after related donor allogeneic hematopoietic cell transplantation (HCT). Biol Blood Marrow Transplant 2008;14:1017-21.
29. Srinivasan A, Kasow KA, Cross S, et al. Phase I study of the tolerability and pharmacokinetics of palifermin in children undergoing allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2012;18:1309-14.
30. Lauritano D, Petruzzi M, Di Stasio D, et al. Clinical effectiveness of palifermin in prevention and treatment of oral mucositis in children with acute lymphoblastic leukaemia: a case-control study. Int J Oral Sci 2014;6:27-30.
31. Vitale K, Violago L, Cofnas P, et al. Impact of palifermin on incidence of oral mucositis and healthcare utilization in children undergoing autologous hematopoietic stem cell transplantation for malignant diseases. Pediatr Transplant 2014;18:211-16.
32. Grzegorczyk-Jazwinska A, Kozak I, Karakulska-Prystupiuk E, et al. Transient oral cavity and skin complications after mucositis preventing therapy (palifermin) in a patient after allogeneic PBSCT. Case history. Adv Med Sci 2006;51(Suppl 1):66-8.
33. Ladenstein R, Valteau-Couanet D, Brock P, et al. Randomized trial of prophylactic granulocyte colony-stimulating factor during rapid COJEC induction in pediatric patients with high-risk neuroblastoma: the European HR-NBL1/SIOPEN study. J Clin Oncol 2010;28:3516-24.
34. Lehrnbecher T, Zimmermann M, Reinhardt D, et al. Prophylactic human granulocyte colony-stimulating factor after induction therapy in pediatric acute myeloid leukemia. Blood 2007;109:936-43.
35. Michel G, Landman-Parker J, Auclerc MF, et al. Use of recombinant human granulocyte colony-stimulating factor to increase chemotherapy dose-intensity: a randomized trial in very high-risk childhood acute lymphoblastic leukemia. J Clin Oncol 2000;18:1517-24.
36. Patte C, Laplanche A, Bertozzi AI, et al. Granulocyte colony-stimulating factor in induction treatment of children with non-Hodgkin's lymphoma: a randomized study of the French Society of Pediatric Oncology. J ClinOncol 2002;20:441-8.
37. Sung L, Tomlinson GA, Greenberg ML, et al. Serial controlled N-of-1 trials of topical vitamin E as prophylaxis for chemotherapy-induced oral mucositis in paediatric patients. Eur J Cancer 2007;43:1269-75.
38. de Koning BA, Philipsen-Geerling B, Hoijer M, et al. Protection against chemotherapy induced mucositis by TGF-beta(2) in childhood cancer patients: results from a randomized cross-over study. Pediatr Blood Cancer 2007;48:532-9.
39. Gandemer V, Le Deley MC, Dollfus C, et al. Multicenter randomized trial of chewing gum for preventing oral mucositis in children receiving chemotherapy. J Pediatr Hematol Oncol 2007;29:86-94.
40. Raether D, Walker PO, Bostrum B, et al. Effectiveness of oral chlorhexidine for reducing stomatitis in a pediatric bone marrow transplant population. Pediatr Dent 1989;11:37-42.
41. Shenep JL, Kalwinsky DK, Hutson PR, et al. Efficacy of oral sucralfate suspension in prevention and treatment of chemotherapy-induced mucositis. J Pediatr 1988;113:758-63.
42. Rojas de Morales T, Zambrano O, Rivera L, et al. Oral-disease prevention in children with cancer: testing preventive protocol effectiveness. Medicina Oral 2001;6:326-34.
43. O'Sullivan C, Dupuis LL, Gibson P, et al. Refinement of the Symptom Screening in Pediatrics Tool (SSPedi). Br J Cancer 2014;111:1262-8.
44. Tomlinson D, Dupuis LL, Gibson P, et al. Initial development of the Symptom Screening in Pediatrics Tool (SSPedi). Support Care Cancer 2014;22:71-5.
45. Jacobs S, Baggott C, Agarwal R, et al. Validation of the Children's International Mucositis Evaluation Scale (ChIMES) in paediatric cancer and SCT. Br J Cancer 2013;109:2515-22.
46. Gibson F, Cargill J, Allison J, et al. Establishing content validity of the oral assessment guide in children and young people. Eur J Cancer 2006;42:1817-25.
47. Sung L, Tomlinson GA, Greenberg ML, et al. Validation of the oral mucositis assessment scale in pediatric cancer. Pediatr Blood Cancer 2007;49:149-53.
48. Tomlinson D, Ethier MC, Judd P, et al. Reliability and construct validity of the oral mucositis daily questionnaire in children with cancer. Eur J Cancer 2011;47:383-8.
49. Seifi M, Maghzi A, Gutknecht N, et al. The effect of 904 nm low level laser on condylar growth in rats. Lasers Med Sci 2010;25:61-5.
50. Abtahi M, Poosti M, Saghravanian N, et al. The effect of low level laser on condylar growth during mandibular advancement in rabbits. Head Face Med 2012;8:4.